Researchers analyzed results of the REACT clinical trial to determine whether age affects the safety and efficacy of early combined immunosuppressive treatment in Crohn disease.
The American Gastroenterological Association has published new recommendations on which therapies are best for the management of mild-to-moderate ulcerative colitis.
Maintenance therapy with infliximab—an anti-tumor necrosis factor agent—is standard treatment for moderate to severe pediatric inflammatory bowel disease (IBD).
Researchers performed small RNA sequencing of colon tissue from more than 100 individuals to better understand cellular mechanisms that create heterogeneity in CD.
In a plenary session at ACG 2018, Dr Adeeti Chiplunker from Washington University discussed her research on the effect of magnetic resonance enterography on the management of small bowel Crohn disease. ...
Researchers at Vanderbilt University Medical Center conducted a retrospective study among more than 400 patients with inflammatory bowel disease to evaluate adherence to injectable biologic therapy.
Researchers at Vanderbilt University Medical Center conducted a retrospective study among more than 400 patients with inflammatory bowel disease to evaluate adherence to injectable biologic therapy.
